AbbVie Inc.
ABBV
$162.97
$2.161.34%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -53.77% | -12.15% | 746.86% | -90.34% | -37.38% |
| Total Depreciation and Amortization | -7.11% | -1.11% | 6.25% | -1.39% | -2.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.81% | -38.10% | -44.08% | 35.86% | 3,927.45% |
| Change in Net Operating Assets | -83.24% | 378.80% | 166.91% | -197.52% | -43.56% |
| Cash from Operations | -37.25% | 19.86% | 50.70% | -43.55% | -2.29% |
| Capital Expenditure | 6.39% | -23.03% | -1.71% | 17.84% | -20.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -252.23% | 1.88% | 54.67% | -17.67% | -200.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -700.00% | 333.33% | -110.34% | -55.38% | -95.84% |
| Cash from Investing | -116.80% | -8.21% | 31.66% | -11.38% | -134.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -89,600.00% | 99.80% | 25.83% | 80.28% | -153.65% |
| Issuance of Common Stock | -13.89% | -25.00% | -26.15% | 22.64% | 381.82% |
| Repurchase of Common Stock | 25.00% | 60.00% | 99.49% | -48,775.00% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.04% | -0.08% | 1.35% | -6.19% | -0.08% |
| Other Financing Activities | 10.94% | 80.66% | -14.14% | 11.04% | -1.88% |
| Cash from Financing | -67.19% | 32.12% | 36.69% | 35.73% | -74.59% |
| Foreign Exchange rate Adjustments | 243.75% | -60.00% | -225.00% | -65.22% | 138.98% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -110.45% | 121.09% | 182.25% | 5.36% | -179.46% |
